International cosmetic company Labo has launched two of its cosmetic products in the Kenyan market, giving more options for consumers in the highly competitive beauty industry. The products – Crescina and Fillerina – will be marketed through Medipoint Pharmaceuticals.
Mr Manuel Falsarella, who is the International Sales Manager at Labo International, said the company has a presence in more than 30 countries in Africa represented by Kenya and South Africa.
Fillerina is an anti-skin ageing product that was produced following a study by Labo on skin ageing and skin biological process that saw it being granted nine specific formulation patents. In 2012, the product was introduced as a real breakthrough in skin filling technology.
“Fillerina has two major functions,” said Mr Godfrey Wambaa, the Managing Director of Medipoint Pharmaceuticals, “To correct wrinkles and to improve the microrelief, the aging lines and fine lines; as well as give new volumes to cheekbones and lips.”
As skin ages, the amount of hyaluronic acid gradually declines, causing imperfections such as ageing wrinkles, expression lines and loss of volume; that is, deflation and skin depressions, especially on cheekbones, cheeks, and lips.
Crescina, on the other hand, is a hair treatment product that comes in two formulations for hair thinning and prevention of hair loss. Crescina Re-Growth is suitable for hair thinning while Crescina Anti-Hair Loss is deals with preventing hair loss.
“People think that hair loss is only associated with men. What they do not know is that hair loss is a phenomenon that occurs both in men and women and that it is something that can be treated and prevented,” said Dr Jacque Kavete, a Clinical Dermatologist at Kenyatta National Hospital.
The concentrations of Crescina Re-Growth active ingredients were developed based on the stages of thinning listed in the Hamilton/Ludwig scale.